课题基金 / 基金详情

CYTOMEGALOVIRUS RETINITIS RETREATMENT TRIAL

CYTOMEGALOVIRUS RETINITIS RETREATMENT TRIAL
巨细胞病毒视网膜炎治疗试验
批准号：
5218005
负责人：
MURK-HEIN HEINEMANN
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5218005
关键词：
AIDS AIDS therapy antiviral agents clinical research clinical trials combination chemotherapy cytomegalovirus foscarnet ganciclovir human subject human therapy evaluation opportunistic infections relapse /recurrence retinitis

项目摘要

项目成果

MURK-HEIN HEINEMANN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A multicenter clinical trial whose primary objective is to compare the safety and efficacy of 3 therapeutic regimens for AIDS-related CMV retinitis in patients treated with foscarnet or ganciclovir and whose retinitis progressed or recurred. Also, the safety and efficacy of continuing to treat patients with same anti-CMV drug versus being switched to the alternative drug as a result of randomization will be compared to those assigned by randomization to continue treatment with the same drug.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LONGITUDINAL STUDY OF OCULAR COMPLICATIONS OF AIDS
LONGITUDINAL STUDY OF OCULAR COMPLICATIONS OF AIDS
LONGITUDINAL STUDY OF OCULAR COMPLICATIONS OF AIDS
Longitudinal study of ocular complications of AIDS
海外基金